About 38,855 results

ALLMedicine™ Migraine Center

Research & Reviews  10,846 results

Cardiovascular Disease and Migraine: Are the New Treatments Safe?
https://doi.org/10.1007/s11916-022-01064-4 10.3389/fncel.2018.00233 10.1080/14728222.2020.1724285 10.1111/j.1526-4610.2012.02274.x 10.1016/j.npep.2010.12.002 10.1016/S0008-6363(98)00016-9 10.1177/0333102419863027 10.1177/0333102419867282 10.1177/0333102414547138 10.1136/jnnp-2018-318254 10.1111/head.14001 10.1136/bmj.a636 10.1177/0333102414559551 10.3988/jcn.2021.17.2.164 10.1007/s10072-018-3429-8 10.1136/jnnp.2003.019638 10.1212/WNL.0b013e3181d0cc8b 10.1046/j.1365-2125.1999.00851.x 10.1067/mcp.2000.110502 10.1212/01.WNL.0000110312.36809.7F 10.1111/head.13959 10.1007/s00228-002-0482-1 10.1016/j.clpt.2006.03.011 10.1002/ana.410330109 10.1007/s10194-008-0011-4 10.1111/j.1468-2982.2008.01578.x 10.1177/0333102414544977 10.5505/tjtes.2014.43433 10.1177/1941874418797764 10.1212/WNL.0000000000004108 10.1016/j.pharmthera.2018.01.005 10.1111/bph.14832 10.1038/sj.bjp.0703081 10.1097/j.pain.0000000000001801 10.1186/s10194-020-01138-x 10.1016/j.clinthera.2021.04.004 10.1186/s10194-019-1044-6 10.1002/cpdd.768 10.1111/j.1365-2125.2010.03869.x 10.1177/0333102419884943 10.1002/ana.25831 10.1111/j.1526-4610.2011.02052.x 10.1038/clpt.2011.246 10.1016/S0140-6736(20)32544-7 10.1016/S0140-6736(19)31606-X 10.1177/0333102413500727 10.1056/NEJMoa2035908 10.1016/S1474-4422(20)30234-9 10.1177/03331024211000311 10.1002/cpt.1696 10.1111/head.13862 10.1111/head.14095 10.1111/head.13930 10.1016/S1474-4422(20)30279-9 10.1212/WNL.0000000000009169 10.1177/0333102418759786 10.1056/NEJMoa1705848 10.1016/S0140-6736(18)32534-0 10.1016/S1474-4422(17)30083-2 10.1177/0333102419854082 10.1001/jama.2018.4853 10.1056/NEJMoa1709038 10.1016/S0140-6736(19)31946-4 10.1001/jamaneurol.2018.1212 10.1177/0333102418779543 10.1212/WNL.0000000000006640 10.1111/head.13684 10.1177/0333102420905132 10.1007/s40259-021-00469-8 10.1111/head.13589 10.1212/WNL.0000000000010600 10.1186/s12883-018-1193-2 10.1186/s10194-020-01186-3 10.1186/s10194-020-01193-4 10.1111/head.13414 10.1177/0333102420983292 10.1212/WNL.0000000000010740 10.1186/s10194-017-0807-1
Current Pain and Headache Reports; Robblee J, Harvey LK

Jun 26th, 2022 - The authors present data on cardiovascular safety for the new acute and preventive migraine treatments including ditans, gepants, and calcitonin gene-related peptide monoclonal antibodies (CGRP mAbs) alongside older medications like triptans and e...

Efficacy of contralateral acupuncture in women with migraine without aura: protocol for...
BMJ Open; Li Q, Feng J et. al.

Jun 25th, 2022 - Migraine is a common neurological disorder with a higher prevalence occurring in women. Migraine without aura (MwoA) is the most common type of migraine. In recent years, the safety and effectiveness of acupuncture for migraines have been internat...

Clinical Outcomes Following Implementation of a Formalized "Flashes and Floaters" Emerg...
American Journal of Ophthalmology; Shen BY, Salman AR et. al.

Jun 25th, 2022 - To report outcomes of patients presenting to the emergency department (ED) with new-onset visual flashes and/or floaters following implementation of a formalized triage protocol allowing eligible patients to be discharged for prompt outpatient oph...

Migraine treatment with external concurrent occipital and trigeminal neurostimulation-A...
Headache Tepper SJ, Grosberg B et. al.

Jun 25th, 2022 - To evaluate the efficacy and safety of concurrent non-invasive stimulation of occipital and trigeminal nerves in acute treatment of migraine with or without aura. Non-invasive neuromodulation devices stimulating a single peripheral nerve or anatom...

Lasmiditan for single migraine attack in Japanese patients with cardiovascular risk fac...
Expert Opinion on Drug Safety; Hashimoto Y, Komori M et. al.

Jun 25th, 2022 - Some migraine treatments are contraindicated for patients with cardiovascular disease (CVD) or risk factors (CVRFs). We report safety and efficacy of lasmiditan, a new oral acute migraine treatment with no cardiovascular contraindication, in Japan...

see more →

Guidelines  16 results

Guidelines of the International Headache Society for controlled trials of preventive tr...
Cephalalgia : an International Journal of Headache; Diener HC, Tassorelli C et. al.

Jul 30th, 2020 - Clinical trials are a key component of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for Contro...

ACR Appropriateness Criteria® Cerebrovascular Disease-Child.
Journal of the American College of Radiology : JACR; , Robertson RL et. al.

May 7th, 2020 - Stroke is an uncommon but an important and under-recognized cause of morbidity and mortality in children. Strokes may be due to either brain ischemia or intracranial hemorrhage. Common symptoms of pediatric acute stroke include headache, vomiting,...

Transcranial Magnetic Stimulation for Pain, Headache, and Comorbid Depression: INS-NANS...
Neuromodulation : Journal of the International Neuromodul... Leung A, Shirvalkar P et. al.

Mar 27th, 2020 - While transcranial magnetic stimulation (TMS) has been studied for the treatment of psychiatric disorders, emerging evidence supports its use for pain and headache by stimulating either motor cortex (M1) or dorsolateral prefrontal cortex (DLPFC). ...

Pharmacologic Acute and Preventive Treatment for Migraine in Children and Adolescents.
JAMA Neurology; Szperka CL, VanderPluym JH et. al.

Dec 10th, 2019 - Pharmacologic Acute and Preventive Treatment for Migraine in Children and Adolescents.|2019|Szperka CL,VanderPluym JH,Oakley CB,|prevention & control,

Aids to management of headache disorders in primary care (2nd edition) : on behalf of t...
The Journal of Headache and Pain; Steiner TJ, Jensen R et. al.

May 23rd, 2019 - The Aids to Management are a product of the Global Campaign against Headache, a worldwide programme of action conducted in official relations with the World Health Organization. Developed in partnership with the European Headache Federation, they ...

see more →

Drugs  782 results see all →

Clinicaltrials.gov  1,312 results

CADASIL Disease Discovery

Jun 24th, 2022 - Small vessel diseases are conditions characterized by the narrowing of small arteries leading to an imbalance of blood supply upon demand. This results in a progressive chronic hypoperfusion with detrimental outcomes for the affected organ system ...

Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

Jun 24th, 2022 - Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to light and sound. Migraine is extremely common and disabling in chil...

Family Study of Affective and Anxiety Spectrum Disorders

Jun 24th, 2022 - Objective: The chief goal of this study is to identify the endophenotypes of the spectrum of mood disorders using the methods of genetic epidemiology, developmental psychopathology and clinical psychiatry/psychology. The major research questions f...

Exercise Treatment in Tension Type Headache

Jun 24th, 2022 - Tension-type headache (TTH) is a common type of headache. Its incidence in women has been reported as 18%. It is thought to be associated with stress, contractions in peripheral muscles, and changes in pain transmission and inhibition mechanisms i...

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

Jun 24th, 2022 - Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to light and sound. Migraine is extremely common and disabling in chil...

see more →

News  2,554 results

Promising New Tool for Better Migraine Management in Primary Care

Jun 23rd, 2022 - A new tool can help streamline diagnosis and treatment of migraine in the primary care setting, new research suggests. Early results from a small pilot study showed that the tool, essentially a medical record "best-practice alert," reduces special...

More Positive Phase 3 Results 'Raise the Bar' for Migraine Drug

Jun 23rd, 2022 - Atogepant, a small-molecule calcitonin gene-related peptide (CGRP) receptor antagonist approved last year for migraine, is superior to placebo not only in terms of a 50% or greater responder rate but also for a 75% or greater and 100% responder ra...

Recommended Drugs for Headache Rarely Prescribed in EDs

Jun 23rd, 2022 - DENVER – In line with recommendations, emergency departments dramatically reduced their use of opioids as treatments for headache over a recent 11-year period, a new study finds. But the use of diphenhydramine (Benadryl) more than doubled even tho...

Malpractice Case: How Diagnosis and Handoff Mishaps Led to Patient's Severe Stroke Outcome

Jun 22nd, 2022 - It's well understood that physicians have limited time to treat patients with stroke before the disease progresses and outcomes can worsen. This case illustrates how differing opinions by remote and in-person physicians — followed by system breakd...

Bariatric surgery can be a tool to relieve migraine
Randy Dotinga

Jun 20th, 2022 - DENVER – More than a weight-loss operation, bariatric surgery can also relieve migraine, possibly because of links between head pain and the gut, a neurologist told colleagues at the annual meeting of the American Headache Society. “There’s eviden.

see more →

Patient Education  32 results see all →